Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Pepti

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Pepti head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 75 · Grade C

Pepti

Visit Pepti Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 77 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Pepti a bad call — it's best for shoppers who want one all-in figure per vial with nothing layered on top of it. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
85
Transparency
90
94
Access Breadth
93
90
Clinical Oversight
92
81
Track Record
88
74
CoreAge RxBrief Score 94 · 77Pepti

Price, coverage & the tracker

CoreAge RxPepti
Brief Score94/100 (A)77/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

From $109/mo (28-day cycle, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $179/mo (28-day cycle, compounded)

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and D.C.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Pepti: Compounded treatment starts at $109 per 28-day period, rather than per calendar month. The listed service area covers all 50 states and D.C.; confirm treatment eligibility for your address.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.